Equity Overview
Price & Market Data
Price: $0.636
Daily Change: +$0.0398 / 6.25%
Range: $0.57 - $0.675
Market Cap: $65,498,212
Volume: 702,851
Performance Metrics
1 Week: 14.76%
1 Month: 35.10%
3 Months: 13.31%
6 Months: 9.26%
1 Year: -14.09%
YTD: 5.96%
Company Details
Employees: 85
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally. It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.